Newsroom

AROMICS attended to Catalonia Bio Lessons Learned
- 09/05/2019

AROMICS attended to Catalonia Bio Lessons Learned "The Social Return on Investment in biomedical companies, a rising value?"

Lessons Learned session, on 9 May in the Barcelona Science Park, featured entrepreneurs, investors and heads of organisations working to have an impact on society, who had the opportunity to share their points of view and experience in a dynamic,...   see news

AROMICS' CEO will be present at the SME instrument Wellcome Day
- 22/05/2019

AROMICS' CEO will be present at the SME instrument Wellcome Day

AROMICS Chief Executive Officer and co-founder,  Dr. Carmen Plasencia, is one participants in the event organized by the European Innovation Council (EIC) pilot dedicated to SME Phase 2 Insturment funded projects.  The company...   see news

THE BERMES PROJECT INCLUDED IN THE ORPHANET DATABASE
- 25/04/2019

THE BERMES PROJECT INCLUDED IN THE ORPHANET DATABASE

Orphanet is the reference information portal on rare diseases and orphan drugs aimed at all audiences. The aim of Orphanet is to contribute to the improvement of the diagnosis, care and treatment of patients with rare diseases. Due to its incidence,...   see news

AROMICS' Ceo Dr. Plasencia will be present at PhD day of IDIBELL
- 10/04/2019

AROMICS' Ceo Dr. Plasencia will be present at PhD day of IDIBELL

Dr. Carmen Plasencia, CEO and co-founder of AROMICS, will participate in the round table “Women in Science” at the PhD Day at IDIBELL. The meeting aims to be a place of interaction between scientists and their innovation ecosystems around...   see news

AROMICS receives the Seal for Innovative SME from Spanish Ministry of Science, Innovation and Universities
- 08/04/2019

AROMICS receives the Seal for Innovative SME from Spanish Ministry of Science, Innovation and Universities

The Spanish Ministry of Science, Innovation and Universities recognized the innovation and advances of Aromics in developing novel therapies for highly unmet medical needs. The seal awards companies that have proven, with its trajectory and activity,...   see news

AROMICS' CEO will be present at the Empowering Women in Tech Event
- 04/04/2019

AROMICS' CEO will be present at the Empowering Women in Tech Event

AROMICS Chief Executive Officer and co-founder,  Dr. Carmen Plasencia, is one of the women entrepreneurs invited to participate in the event organized by the European Innovation Council (EIC) pilot dedicated to Women in Tech. The event...   see news

AROMICS will participate in Bioequity 2019
- 13/03/2019

AROMICS will participate in Bioequity 2019

AROMICS and its Bermes project will be present at Bio€quity 2019, the main investors’ event dedicated to the European biopharmaceutical industry, which will take place in Barcelona on 20th and 21st May 2019 at the Crowne Plaza Hotel. ...   see news

AROMICS receives 1 Million Euros to advance in its therapy for cancer
- 13/03/2019

AROMICS receives 1 Million Euros to advance in its therapy for cancer

The European Commission has allocated, through the H2020-EIC-SMEInst-2018-2020-Phase 2 program,  a total of 1,085.659€ to the BERMES project of Aromics, the objective of which is to complete the regulatory pre-clinical stage in order to begin...   see news

- 14/02/2019

The biotech company Aromics recieves 1 M€ from the European Union to boost its drug against the asbestos-related hallmark cancer

The European Commission has allocated, through the H2020-EIC-SMEInst-2018-2020-Phase 2 program,  a total of 1,085.659€ to the BERMES project of Aromics, the objective of which is to complete the regulatory pre-clinical stage in order to begin...   see news

12/03/2019

BERMES project seeks to develop a new cure for Malignant Mesothelioma

The European Commission has allocated, through the H2020-EIC-SMEInst-2018-2020-Phase 2 program,  a total of 1,085.659€ to the BERMES project of Aromics, the objective of which is to complete the regulatory pre-clinical stage in order to begin... see publication

- 30/01/2019

AROMICS launches BERMES website

Visit BERMES website and know more about the project goal and advances.

http://www.bermesproject.eu

  see news

- 01/11/2018

AROMICS receives Horizon 2020 SME instrument funding to develop a new therapy for malignant mesothelioma

BERMES, a proposal submitted by the Spanish biotechnology company AROMICS, has been selected to receive EU funding from H2020 SME Instrument Phase II topic. This grant represents the first big step forward for the company as it looks for bringing the...   see news

European Union